MENU
NRBO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
NeuroBo Pharmaceuticals (NRBO) Ownership - Who owns NeuroBo Pharmaceuticals?
Profile
Industry
N/A
Address
545 Concord Avenue
Phone
+1 857 702-9600
Employees
8
Web
https://www.neurobopharma.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
20.59M
P/E Ratio
13.00
Total Cash
15.99M
Projected Growth
N/A
Total Debt
187K
Revenue
N/A
Risk (Beta)
0.23
Dividend Yield
N/A
Total Cash/Share
1.86
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
NRBO
Capitalization
20.6M
P/E Ratio
13.00
Risk (Beta)
0.23
Dividend Yield
N/A
Total Cash
16M
Total Cash/Share
1.86
Total Debt
187K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
N/A
ROE
N/A
Book Value
10.1M
P/B Ratio
1.59
Cash Flow
N/A
Earnings
N/A
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
2.46
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
N/A
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
N/A
Shares Held By Institutions
4.64M
Shares Outstanding - Current
8.62M
Total Liabilities
6.94M
Total Volume MTD
N/A
Value
N/A
Gain YTD
-35.346
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a clinical-stage biotechnology company focused on developing novel pharmaceuticals to treat neurodegenerative disorders.
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
545 Concord Avenue
Phone
+1 857 702-9600
Employees
8
Web
https://www.neurobopharma.com